TIEUX Morgan Stanley Pathway Intl Eq Forecast, Technical & Fundamental Analysis

The most notable companies in this group are AstraZeneca PLC (NYSE:AZN).

The investment seeks capital appreciation. The fund will invest, under normal market conditions, at least 80% of its net assets (plus the amount of any borrowing for investment purposes) in the equity securities of companies located outside the U.S. The advisor focuses on companies located in developed markets, but also may invest a portion of its assets in securities of companies located in emerging markets. The advisor intends to diversify its assets by investing primarily in securities of issuers located in at least three foreign countries. It may also lend portfolio securities to earn additional income.

The average market capitalization across the Morgan Stanley Pathway Intl Eq MF is 243.61B. The market cap for tickers in the group ranges from 38.42B to 659.24B. ASML holds the highest valuation in this group at 659.24B. The lowest valued company is ROP at 38.42B.

The average weekly volume growth across all stocks in the Morgan Stanley Pathway Intl Eq MF was -22%. For the same stocks of the MF, the average monthly volume growth was -13% and the average quarterly volume growth was -24%